Weiner LM - Search Results

1

Ajina R, Weiner LM. Ajina R, et al. Among authors: weiner lm. Pancreas. 2020 Sep;49(8):1014-1023. doi: 10.1097/MPA.0000000000001621. Pancreas. 2020. PMID: 32833941 Free PMC article. Review.

2

Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.

Cohen SJ, Alpaugh RK, Palazzo I, Meropol NJ, Rogatko A, Xu Z, Hoffman JP, Weiner LM, Cheng JD. Cohen SJ, et al. Among authors: weiner lm. Pancreas. 2008 Aug;37(2):154-8. doi: 10.1097/MPA.0b013e31816618ce. Pancreas. 2008. PMID: 18665076

3

Monoclonal antibodies for the treatment of cancer.

Shuptrine CW, Surana R, Weiner LM. Shuptrine CW, et al. Among authors: weiner lm. Semin Cancer Biol. 2012 Feb;22(1):3-13. doi: 10.1016/j.semcancer.2011.12.009. Epub 2012 Jan 8. Semin Cancer Biol. 2012. PMID: 22245472 Free PMC article. Review.

4

Cancer immunology for the clinician.

Weiner LM. Weiner LM. Clin Adv Hematol Oncol. 2015 May;13(5):299-306. Clin Adv Hematol Oncol. 2015. PMID: 26352774 Review.

5

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.

Beglyarova N, Banina E, Zhou Y, Mukhamadeeva R, Andrianov G, Bobrov E, Lysenko E, Skobeleva N, Gabitova L, Restifo D, Pressman M, Serebriiskii IG, Hoffman JP, Paz K, Behrens D, Khazak V, Jablonski SA, Golemis EA, Weiner LM, Astsaturov I. Beglyarova N, et al. Among authors: weiner lm. Clin Cancer Res. 2016 Dec 15;22(24):6153-6163. doi: 10.1158/1078-0432.CCR-16-0149. Epub 2016 Jul 6. Clin Cancer Res. 2016. PMID: 27384421 Free PMC article.

6

Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.

Murakami S, Shahbazian D, Surana R, Zhang W, Chen H, Graham GT, White SM, Weiner LM, Yi C. Murakami S, et al. Among authors: weiner lm. Oncogene. 2017 Mar 2;36(9):1232-1244. doi: 10.1038/onc.2016.288. Epub 2016 Aug 22. Oncogene. 2017. PMID: 27546622 Free PMC article.

7

An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection.

Shuptrine CW, Ajina R, Fertig EJ, Jablonski SA, Kim Lyerly H, Hartman ZC, Weiner LM. Shuptrine CW, et al. Among authors: weiner lm. Cancer Immunol Immunother. 2017 Dec;66(12):1529-1544. doi: 10.1007/s00262-017-2047-2. Epub 2017 Aug 2. Cancer Immunol Immunother. 2017. PMID: 28770278 Free PMC article.

8

Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.

Smith JP, Wang S, Nadella S, Jablonski SA, Weiner LM. Smith JP, et al. Among authors: weiner lm. Cancer Immunol Immunother. 2018 Feb;67(2):195-207. doi: 10.1007/s00262-017-2077-9. Epub 2017 Oct 17. Cancer Immunol Immunother. 2018. PMID: 29043413 Free PMC article.

9

Functional genomics: paving the way for more successful cancer immunotherapy.

Ajina R, Zamalin D, Weiner LM. Ajina R, et al. Among authors: weiner lm. Brief Funct Genomics. 2019 Mar 22;18(2):86-98. doi: 10.1093/bfgp/ely017. Brief Funct Genomics. 2019. PMID: 29762641 Free PMC article. Review.

10

SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice.

Ajina R, Zamalin D, Zuo A, Moussa M, Catalfamo M, Jablonski SA, Weiner LM. Ajina R, et al. Among authors: weiner lm. Oncoimmunology. 2019 Mar 16;8(5):e1577127. doi: 10.1080/2162402X.2019.1577127. eCollection 2019. Oncoimmunology. 2019. PMID: 31069138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters